These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 3005214

  • 1. Immunoactive peptides, FK 156 and FK 565. IV. Activation of mouse macrophages.
    Watanabe Y, Tawara S, Mine Y, Kikuchi H.
    J Antibiot (Tokyo); 1985 Dec; 38(12):1781-7. PubMed ID: 3005214
    [Abstract] [Full Text] [Related]

  • 2. Immunoactive peptides, FK-156 and FK-565. III. Enhancement of host defense mechanisms against infection.
    Mine Y, Watanabe Y, Tawara S, Yokota Y, Nishida M, Goto S, Kuwahara S.
    J Antibiot (Tokyo); 1983 Aug; 36(8):1059-66. PubMed ID: 6630057
    [Abstract] [Full Text] [Related]

  • 3. Mitogenic potentials of bestatin, amastatin, arphamenines A and B, FK-156 and FK-565 on spleen lymphocytes.
    Weissmann N, Leyhausen G, Maidhof A, Tanaka W, Umezawa H, Müller WE.
    J Antibiot (Tokyo); 1985 Jun; 38(6):772-8. PubMed ID: 4019321
    [Abstract] [Full Text] [Related]

  • 4. Immunoactive peptides, FK-156 and FK-565. II. Restoration of host resistance to microbial infection in immunosuppressed mice.
    Yokota Y, Mine Y, Wakai Y, Watanabe Y, Nishida M, Goto S, Kuwahara S.
    J Antibiot (Tokyo); 1983 Aug; 36(8):1051-8. PubMed ID: 6415030
    [Abstract] [Full Text] [Related]

  • 5. Immunoactive peptides, FK-156 and FK-565. I. Enhancement of host resistance to microbial infection in mice.
    Mine Y, Yokota Y, Wakai Y, Fukada S, Nishida M, Goto S, Kuwahara S.
    J Antibiot (Tokyo); 1983 Aug; 36(8):1045-50. PubMed ID: 6415029
    [Abstract] [Full Text] [Related]

  • 6. Activation by a new synthetic acyltripeptide and its analogs entrapped in liposomes of rat alveolar macrophages to the tumor cytotoxic state.
    Sone S, Mutsuura S, Ogawara M, Utsugi T, Tsubura E.
    Cancer Immunol Immunother; 1984 Aug; 18(3):169-73. PubMed ID: 6568873
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vivo activation of functional properties in mouse peritoneal macrophages by Nocardia rubra cell wall skeleton.
    Mine Y, Watanabe Y, Tawara S, Nonoyama S, Yokota Y, Kikuchi H.
    Arzneimittelforschung; 1986 Nov; 36(11):1651-5. PubMed ID: 3028437
    [Abstract] [Full Text] [Related]

  • 12. Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitro.
    Ahmed K, Turk JL.
    Cancer Immunol Immunother; 1989 Nov; 28(2):87-92. PubMed ID: 2783891
    [Abstract] [Full Text] [Related]

  • 13. Studies on a new immunoactive peptide, FK-156. II. Fermentation, extraction and chemical and biological characterization.
    Gotoh T, Nakahara K, Nishiura T, Hashimoto M, Kino T, Kuroda Y, Okuhara M, Kohsaka M, Aoki H, Imanaka H.
    J Antibiot (Tokyo); 1982 Oct; 35(10):1286-92. PubMed ID: 6757224
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Synthesis and adjuvant activity of FK-156 analogues: acyl derivatives of N-[N2-(L-alanyl-gamma-D-glutamyl)-2(L),2'(D)-diamino-1-pimeloyl ]glycine.
    Okada S, Takeno H, Hemmi K, Kitaura Y, Hashimoto M.
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):889-92. PubMed ID: 4017131
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on a new immunoactive peptide, FK-156. IV. Synthesis of FK-156 and its geometric isomer.
    Hemmi K, Aratani M, Takeno H, Okada S, Miyazaki Y, Nakaguchi O, Kitaura Y, Hashimoto M.
    J Antibiot (Tokyo); 1982 Oct; 35(10):1300-11. PubMed ID: 7174517
    [Abstract] [Full Text] [Related]

  • 19. The role of superoxide anion and lysosomal enzymes in anti-listerial activity of elicited peritoneal macrophages.
    Hashimoto S, Nomoto K, Yokokura T.
    Scand J Immunol; 1986 Oct; 24(4):429-36. PubMed ID: 3020680
    [Abstract] [Full Text] [Related]

  • 20. Oral administration of a streptococcal agent OK-432 activates peritoneal macrophages in mice.
    Suzuki I, Kinoshita A, Tanaka H, Yadomae T.
    Int J Immunopharmacol; 1991 Oct; 13(2-3):147-54. PubMed ID: 2071291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.